Drug Delivery Products

  • ID: 4532853
  • Report
  • 373 Pages
  • The Freedonia Group
1 of 3
Drug Delivery Products

Drug delivery product demand in the US is projected to expand to $251 billion in 2019, with annual growth of 6.1 percent. As the US population expands and ages, domestic manufacturing and consumption of ethical and over-the-counter medicines and nutritional preparations are expected to rise. Commercialization of drug delivery systems and technologies will increase as generic and private label competition intensifies, drug patent protections expire, and pressure grows to hold down medication prices.

This report segments the drug delivery product market by Oral Products, Parenteral Products, and Other Products. These include:

Oral Products: Controlled-release, chewable, nanoparticulate, orally disintegrating, and transmucosal (or buccal) classifications

Parenteral Products: therapeutic monoclonal antibodies, encapsulated systems, infusion systems, and parenteral delivery devices

Other Products: inhalation, transdermal, and implantable therapies

Oral dosage formulations have historically comprised the largest selling group of drug delivery products, and will remain that way through 2019. Total growth will be somewhat hampered by increasing generic competition and reduced pricing flexibility. Parenteral products, including pen injectors and retractable pre-fillable syringes, are expected to post rapid gains as new and existing therapies based monoclonal antibodies contribute to improved effectiveness of treatment for cancer and other long-term disorders.

Therapeutic classes for drug delivery products include the following agents:

Central nervous system

Hormones and related

Respiratory

Cardiovascular

Gastrointestinal

Nutritional

Other Pharmaceutical

Central nervous system agents control the largest slice of demand for drug delivery product market by therapeutic class, accounting for more than 25 percent of sales. This trend is expected to continue as treatment of psychological and neurological disorders through continuous dosing, controlled-release medicines becomes increasingly prevalent.

This study also details market share and sales estimates for 30 key participants in the drug delivery products industry. These include Allergan, Animas, AstraZeneca, CareFusion, Evonik, GlaxoSmithKline, Hospira, Johnson & Johnson, Novartis, Pfizer, and Roche.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
General
Economic Factors
Demographic Patterns
Healthcare Trends
Health Insurance Reforms
Medical Conditions
Acute Conditions
Chronic Conditions
National Health Expenditures
Spending Categories
Funding Sources
Medical Providers
Hospitals
Outpatient Facilities
Physicians
Skilled Nursing Homes
Patient Activity
Hospital Activity
Outpatient Activity
Surgical Procedures
Pharmaceutical Industry Overview
Regulation
Research & Development
Product Demand
Therapeutic Groups
Dosage Formulations
Regulatory Classes
Commercial Status
III. DRUG DELIVERY PRODUCT OVERVIEW
General
Types of Drug Delivery Products
Historical Market Trends
US Trade
International Markets
IV. ORAL DRUG DELIVERY PRODUCTS
General
Controlled-Release Formulations
Film-Coated Formulations
Diffusion Formulations
Reservoir Formulations
Chewable Tablets
Orally Disintegrating Tablets
Nanoparticulate Formulations
Transmucosal Formulations
V. PARENTERAL DRUG DELIVERY PRODUCTS
General
Therapeutic Monoclonal Antibodies
Technology
Products
HUMIRA (adalimumab)
REMICADE (infliximab)
RITUXAN (rituximab)
AVASTIN (bevacizumab)
HERCEPTIN (trastuzumab)
LUCENTIS (ranibizumab)
STELARA (ustekinumab)
XOLAIR (omalizumab)
TYSABRI (natalizumab)
Other Monoclonal Antibodies
New Products
Developmental Products
Encapsulated Parenteral Formulations
Polymer-Protected Formulations
PEG-Based Parenteral Therapies
Other Polymer-Protected Parenteral Therapies
Developmental Activities
Liposomes
Technology
Marketed Products
Developmental Activities
Infusion Products
IV Administration Sets
Premixed IV Solutions
Infusion Pumps
Other Infusion Products
Enteral Feeding Supplies
IV Accessories
Parenteral Devices
Prefillable Syringes
Injectors
Cartridge Systems
Hypodermic Syringes
IV Catheters
Other Parenteral Devices
VI. OTHER DRUG DELIVERY PRODUCTS
General
Inhalation Drug Delivery Products
Dry Powder Formulations
Metered Dose Formulations
Transdermal Drug Delivery Products
Transdermal Technologies
Central Nervous System Agents
Hormones & Related Agents
Cardiovascular Agents
Other Transdermal Patches
Implantable Drug Delivery Products
Drug Inserts
Drug-Eluting Stents
Other Implantable Drug Delivery Products
Brachytherapy Products
Implantable Drug Pumps
VII. APPLICATIONS
General
Central Nervous System Agents
Controlled-Release Formulations
Other Oral Drug Delivery Products
Transdermal Formulations
Monoclonal Antibodies & Polymer Encapsulated Therapies
Liposomes
Other Drug Delivery Products
Hormones & Related Agents
Anticancer Monoclonal Antibodies
Encapsulated Polymers
Liposomes
Insulin Pen Injectors
Controlled-Release & Other Oral Drug Delivery Products
Transdermal Hormones & Related Agents
Other Drug Delivery Products
Respiratory Agents
Dry Powder Inhalers
Metered Dose Inhalers
Monoclonal Antibodies
Anti-Infective Agents
Cardiovascular Agents
Controlled-Release Formulations
Monoclonal Antibodies
Drug-Eluting Stents
Transdermal Patches
Gastrointestinal Agents
Nutritional Agents
Other Pharmaceuticals
VIII. INDUSTRY STRUCTURE
General
Market Share
Dosage Formulations
Devices
Competitive Strategies
Mergers & Acquisitions
Licensing & Related Agreements
Marketing & Distribution
Manufacturing
Company Profiles
Abbott Laboratories
AbbVie Incorporated
Actavis, see Allergan
Adare Pharmaceuticals Incorporated
Allergan plc
Amgen Incorporated
Animas, see Johnson & Johnson
Aptalis Pharma, see Allergan
Aptalis Pharmaceutical Technologies, see Adare Pharmaceuticals
AptarGroup Incorporated
AstraZeneca plc
Baxter International Incorporated
Becton, Dickinson, and Company
Boehringer Ingelheim GmbH
Braun (B.) Melsungen AG
Bristol-Myers Squibb Company
CareFusion, see Becton, Dickinson
Evonik Industries AG
Forest Laboratories, see Allergan
Genentech, see Roche Holding
Genzyme, see Sanofi
Gerresheimer AG
Gilead Sciences Incorporated
GlaxoSmithKline plc
Hospira, see Pfizer
ImClone Systems, see Lilly (Eli)
Janssen Pharmaceuticals, see Johnson & Johnson
Johnson & Johnson
Lilly (Eli) and Company
MedImmune, see AstraZeneca
Merck & Company Incorporated
Nitto Denko Corporation
Novartis AG
Novo Nordisk A/S
Pfizer Incorporated
Regeneron Pharmaceuticals, see Sanofi
Roche Holding Limited
Sanofi
Teva Pharmaceutical Industries Limited
3M Company
Unilife Corporation
Vetter Pharma International GmbH
West Pharmaceutical Services Incorporated
Additional Companies in the Drug Delivery Product Market
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
Summary Table
SECTION II -- MARKET ENVIRONMENT
1 Macroeconomic Indicators
2 Resident Population by Age Group
3 Health Insurance Coverage of the US Population, 2004-2014
4 Acute Conditions by Type
5 Chronic Conditions by Type
6 National Health Expenditures by Spending Category
7 National Health Expenditures by Funding Source
8 Medical Providers by Type
9 Patient Activity by Type
10 Pharmaceutical Demand by Therapeutic Class
11 Pharmaceutical Demand by Dosage Formulation
12 Pharmaceutical Demand by Regulatory Classification
13 Pharmaceutical Demand by Patent Status
SECTION III -- DRUG DELIVERY PRODUCT OVERVIEW
1 Drug Delivery Product Demand by Type
2 Drug Delivery Product Demand Patterns, 2004-2014
3 US Trade in Drug Delivery Products
4 World Drug Delivery Product Demand by Region
SECTION IV -- ORAL DRUG DELIVERY PRODUCTS
1 Oral Drug Delivery Product Demand by Type
2 Controlled-Release Oral Drug Delivery Product Demand
3 Film-Coated Oral Drug Delivery Product Demand
4 Diffusion Oral Drug Delivery Product Demand
5 Reservoir Oral Drug Delivery Product Demand
6 Chewable Tablet Product Demand by Therapeutic Class
7 Orally Disintegrating Tablet Demand by Therapeutic Class
8 Oral Nanoparticulate Drug Delivery Product Demand by Therapeutic Class
9 Transmucosal Drug Delivery Product Demand by Therapeutic Class
SECTION V -- PARENTERAL DRUG DELIVERY PRODUCTS
1 Parenteral Drug Delivery Product Demand by Type
2 Therapeutic Monoclonal Antibody Demand by Therapeutic Class
3 Encapsulated Parenteral Product Demand by Type
& Therapeutic Class
4 Infusion Product Demand by Type
5 Parenteral Device Demand by Type
SECTION VI -- OTHER DRUG DELIVERY PRODUCTS
1 Other Drug Delivery Product Demand by Type
2 Inhalation Drug Delivery Product Demand by Type
3 Dry Powder Inhaler Demand
4 Metered Dose Inhaler Demand
5 Transdermal Drug Delivery Product Demand by Therapeutic Class
6 Implantable Drug Delivery Product Demand by Type
7 Drug Insert Demand by Therapeutic Class
8 Drug-Eluting Stent Demand
9 Other Implantable Drug Delivery Product Demand by Type
SECTION VII -- APPLICATIONS
1 Drug Delivery Product Demand by Therapeutic Class
2 Central Nervous System Drug Delivery Product Demand by Type
3 Hormone & Related Drug Delivery Product Demand by Type
4 Respiratory Drug Delivery Product Demand by Type
5 Anti-Infective Drug Delivery Product Demand by Type
6 Cardiovascular Drug Delivery Product Demand by Type
7 Gastrointestinal Drug Delivery Product Demand by Type
8 Nutritional Preparation Delivery Product Demand by Type
9 Other Application Drug Delivery Product Demand by Type
SECTION VIII -- INDUSTRY STRUCTURE
1 US Drug Delivery Product Sales by Company, 2014
2 Selected Acquisitions & Divestitures
3 Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- DRUG DELIVERY PRODUCT OVERVIEW
1 Drug Delivery Product Demand by Type, 2014
SECTION V -- PARENTERAL DRUG DELIVERY PRODUCTS
1 Parenteral Drug Delivery Product Demand by Type, 2014
SECTION VII -- APPLICATIONS
1 Drug Delivery Product Demand by Therapeutic Class, 2014
SECTION VIII -- INDUSTRY STRUCTURE
1 Drug Delivery Formulations, US Market Share, 2014
2 Drug Delivery Devices, US Market Share, 2014
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll